Imatinib-induced postoperative periorbital purpura: GASP (Gleevec-Associated Surgical Purpura) in a woman with imatinib-treated chronic myelogenous leukemia
General Material Designation
[Article]
First Statement of Responsibility
Anzalone, C Lane; Cohen, Philip R; Kurzrock, Razelle; Cortes, Jorge E
SUMMARY OR ABSTRACT
Text of Note
Background: Imatinib mesylate is a selective tyrosine kinase inhibitor used in the treatment of chronic myelogenous leukemia. Ocular side effects of imatinib include periorbital edema, which may become so severe as to obstruct the visual field.
SET
Date of Publication
2014
Title
Dermatology Online Journal
Volume Number
20/1
PERSONAL NAME - PRIMARY RESPONSIBILITY
Entry Element
Anzalone, C Lane; Cohen, Philip R; Kurzrock, Razelle; Cortes, Jorge E